Literature DB >> 2791274

Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting.

I F McDowell1, G B Wisdom, E R Trimble.   

Abstract

Polymorphism at the apolipoprotein E (ApoE) locus is an important factor in the development of remnant (Type III) hyperlipidemia and also influences the distribution of cholesterol concentrations in the population. The new method for ApoE phenotyping described here gives good results with simple apparatus. Serum (10 microL) is digested with sialidase (EC 3.2.1.18), delipidated, and redissolved in 6 mol/L urea. Electrofocusing is carried out in agarose, followed by immunoblotting with a monoclonal antibody to ApoE and an anti-immunoglobulin-peroxidase conjugate. Sialidase-catalyzed digestion effectively removes sialated forms of ApoE, which eases interpretation. This method can be used in nonspecialist laboratories and is particularly suited for assay of large numbers of samples.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791274

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

Review 1.  ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.

Authors:  A F Winder; W Richmond; D T Vallance
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

2.  Apolipoprotein E polymorphism in alagille syndrome and progressive familial intrahepatic cholestasis.

Authors:  P Socha; G Nowicka; I Jankowska; J Rujner; J Pawłowska; J Socha
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

3.  Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.

Authors:  A K Soutar; P N Hawkins; D M Vigushin; G A Tennent; S E Booth; T Hutton; O Nguyen; N F Totty; T G Feest; J J Hsuan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

4.  A fast and cost-effective method for apolipoprotein E isotyping as an alternative to APOE genotyping for patient screening and stratification.

Authors:  Olga Calero; Luis García-Albert; Andrés Rodríguez-Martín; Sergio Veiga; Miguel Calero
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.